Literature DB >> 19234828

Hyperventilation versus standard ventilation for infants in postoperative care for congenital heart defects with pulmonary hypertension.

Takako Umenai1, Nobuaki Shime, Satoru Hashimoto.   

Abstract

PURPOSE: In infants undergoing surgery for cardiac defects with left-to-right shunt, a hyperventilation strategy has been applied to prevent pulmonary hypertensive crisis (PHC). Hyperventilation with a large tidal volume and/or higher airway pressure, however, may be detrimental to the lung. This randomized study compared the effects of hyperventilation versus standard ventilation.
METHODS: We enrolled 22 infants with a preoperative pulmonary-to-systemic blood pressure ratio of more than 0.7. Hyperventilation, with a tidal volume of 10-12 ml x kg(-1) to keep Pa(CO2) between 30 and 35 mmHg, was randomly applied in 11 patients for 16 h or more. The other 11 patients were randomly assigned to standard ventilation, with a 6- to 8- ml x kg(-1) tidal volume.
RESULTS: The peak inspiratory pressure was higher (20 +/- 3 vs 18 +/- 2 cmH2O; P = 0.018), and Pa(CO2) (34 +/- 5 vs 42 +/- 7 mmHg; P = 0.003) and positive end-expiratory pressure (3 +/- 0 vs 5 +/- 0; P < 0.0001) were significantly lower in the hyperventilation than in the standard ventilation group. The Pa(CO2)/inspiratory fraction of oxygen Pa(CO2) ratio decreased from 244 +/- 160 mmHg at the onset of postoperative ventilation, to 177 +/- 96 mmHg at 24 h (P = 0.038) in the hyperventilation group, versus a decrease from 240 +/- 89 to 220 +/- 97 mmHg in the standard ventilation group not significant (NS). Serum interleukin (IL)-6 level, measured at 24 h postoperatively, was significantly lower (P = 0.02) in the standard ventilation than in the hyperventilation group, suggesting an attenuated postoperative systemic inflammatory response. A single patient in each group developed PHC.
CONCLUSION: Hyperventilation may cause lung injury and systemic inflammation in infants with pulmonary hypertension undergoing corrective heart surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234828     DOI: 10.1007/s00540-008-0682-7

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  25 in total

Review 1.  Normal responses to injury prevent systemic inflammation and can be immunosuppressive.

Authors:  R S Munford; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

2.  Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome.

Authors:  V M Ranieri; F Giunta; P M Suter; A S Slutsky
Journal:  JAMA       Date:  2000-07-05       Impact factor: 56.272

3.  Epidemiology of bronchopulmonary dysplasia.

Authors:  W H Tooley
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

4.  Pulmonary artery hypertension: is it really a contraindicating factor for early extubation in children after cardiac surgery?

Authors:  Vladimiro L Vida; Juan Leon-Wyss; Milagros Rojas; Ricardo Mack; Joaquin Barnoya; Aldo R Castañeda
Journal:  Ann Thorac Surg       Date:  2006-04       Impact factor: 4.330

5.  Controversies in management of persistent pulmonary hypertension of the newborn.

Authors:  R Sahni; J T Wung; L S James
Journal:  Pediatrics       Date:  1994-09       Impact factor: 7.124

6.  Neutrophil number and interleukin-8 and elastase concentrations in bronchoalveolar lavage fluid correlate with decreased arterial oxygenation after cardiopulmonary bypass.

Authors:  N Kotani; H Hashimoto; D I Sessler; M Muraoka; J S Wang; M F O'Connor; A Matsuki
Journal:  Anesth Analg       Date:  2000-05       Impact factor: 5.108

7.  Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function.

Authors:  H Wrigge; J Zinserling; F Stüber; T von Spiegel; R Hering; S Wetegrove; A Hoeft; C Putensen
Journal:  Anesthesiology       Date:  2000-12       Impact factor: 7.892

8.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

Authors:  V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

9.  Comparison of hyperventilation and inhaled nitric oxide for pulmonary hypertension after repair of congenital heart disease.

Authors:  K Morris; M Beghetti; A Petros; I Adatia; D Bohn
Journal:  Crit Care Med       Date:  2000-08       Impact factor: 7.598

10.  Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study.

Authors:  O I Miller; S F Tang; A Keech; N B Pigott; E Beller; D S Celermajer
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

View more
  3 in total

Review 1.  Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery.

Authors:  Nathan Brunner; Vinicio A de Jesus Perez; Alice Richter; François Haddad; André Denault; Vanessa Rojas; Ke Yuan; Mark Orcholski; Xiaobo Liao
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

2.  Neonatal ventilatory techniques - which are best for infants born at term?

Authors:  Olie Chowdhury; Anne Greenough
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

3.  Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children? - a prospective randomized study.

Authors:  Vipul Krishen Sharma; Saajan Joshi; Ankur Joshi; Gaurav Kumar; Harmeet Arora; Anurag Garg
Journal:  Ann Card Anaesth       Date:  2015 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.